ArticleBJU international2022

TUXEDO: A phase I/II trial of cetuximab with chemoradiotherapy in muscle-invasive bladder cancer.

Nicholas D James et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.